ReviewJournal of personalized medicine2024
Chatbots in Cancer Applications, Advantages and Disadvantages: All that Glitters Is Not Gold.
Review in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The waiting room of uncertainty: digital patient support for potentially bad news-a scoping review.Frontiers in digital health · 2025Pooled it
- Exploring Breast Cancer Survivors' Preferences for Text Messaging-Based Mobile Health Interventions Targeting Sleep and Physical Activity: Qualitative Study.JMIR formative research · 2026Article
- Lessons Learned From Implementing a Culturally Tailored Virtual Support Program for Asian American Breast Cancer Survivors With Pain and Depression.Journal of medical Internet research · 2026Article
- Article
- Greek Physicians' Skills and Factors Affecting Breaking Bad News to Cancer Patients.Current oncology (Toronto, Ont.) · 2026Article
- Empathic AI for Patient-Centered Cancer Care: A Scoping Review of Patient Navigation, Support, and Clinical Practice.JMIR cancer · 2026Article
- Evaluation of Cancer Survivors' Experience of Using AI-Based Conversational Tools: Qualitative Study.JMIR cancer · 2025Article
- Evidence-Based Analysis of AI Chatbots in Oncology Patient Education: Implications for Trust, Perceived Realness, and Misinformation Management.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025Review
- Empowering breast cancer clients through AI chatbots: transforming knowledge and attitudes for enhanced nursing care.BMC nursing · 2025Article
- Opportunities and Challenges of Chatbots in Ophthalmology: A Narrative Review.Journal of personalized medicine · 2024Review
- Alternative Cancer Therapeutics: Unpatentable Compounds and Their Potential in Oncology.Pharmaceutics · 2024Review
- Leveraging AI chatbots in supporting breast and ovarian cancer patients: A scoping review.Digital healthReview
- Information security and confidentiality in health chatbots: A scoping review and development of a conceptual model.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of digitalization and artificial intelligence has had a profound impact on society, especially in the field of medicine. Digital health is now a reality, with an increasing number of people using chatbots for prognostic or diagnostic purposes, therapeutic planning, and monitoring, as well as for nutritional and mental health support. Initially designed for various purposes, chatbots have demonstrated significant advantages in the medical field, as indicated by multiple sources. However, there are conflicting views in the current literature, with some sources highlighting their drawbacks and limitations, particularly in their use in oncology. This state-of-the-art review article seeks to present both the benefits and the drawbacks of chatbots in the context of medicine and cancer, while also addressing the challenges in their implementation, offering expert insights on the subject.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.